Role of calcium-enriched mixture in endodontics

Kabbinale, Pradeep; Chethena, KC; Kuttappa, MA

doi:10.4103/2321-4848.154950

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…49 It showed a high success rate when used as pulpotomy medicament and has gained widespread use a result of its excellent biocompatibility, good sealing ability, low cytotoxicity, and solubility; however, MTA has delayed setting time (about 4 hours), is deemed difficult to manipulate and is expensive to use. 35,50 This material needs to be in contact with water during the setting reaction. The teeth cannot be left unrestored for this time, so a moistened cotton pellet and an interim restoration were left in the teeth until a subsequent appointment.…”

Section: Discussionmentioning

confidence: 99%

Clinical and Radiographic Evaluations of Biodentine™ Pulpotomies in Mature Primary Molars (Stage 2)

Ayoub

Nasrallah

Noueiri

et al. 2018

International Journal of Clinical Pediatric Dentistry

View full text Add to dashboard Cite

Introduction The preservation of the integrity and health of primary teeth and their supporting tissues is of great importance in maintaining arch length space, mastication, speech, and esthetics. A pulpotomy is a common therapy performed on a primary tooth presenting reversible pulpitis or a traumatic pulp exposure, allowing its conservation on the arch until its loss. Aim The study aims to clinically and radiographically evaluate the rates of success and efficacy of Biodentine™ as pulpotomy medicament exclusively on deciduous molars with complete roots formation (stage 2). Materials and methods A total number of 75 primary molars in stage 2 of formation were selected to undergo pulpotomy treatment. All teeth were restored with a stainless-steel crown. The clinical success was evaluated at 1, 3, 6 and 12-month intervals. The radiographic follow-up evaluations were at 6 and 12 months. The resulting data were tabulated and statistically analyzed. Results Among the 75 teeth treated with Biodentine™, one tooth revealed abnormal mobility and tenderness to percussion at the end of the 1st month. PLS widening and the bone lesion was not seen in any of the 74 remaining cases. Forty teeth (54.1%) showed pulp canal obliteration (PCO), and none of the cases developed a draining sinus or had increased mobility. At the end of the 1-year follow-up, the clinical and radiographic success rates were 98.7% and 100%, respectively. Conclusion Pulpotomies performed with Biodentine™ on stage 2 primary molars were generally very satisfactory and fulfilled all requirements, covering all needs. This innovative bioactive medicament seems to be a “heroic” material. The excellent outcomes of the present study are indicative that Biodentine™ is a promising biomaterial to promote pulp repair after pulpotomy in clinical practice. How to cite this article Nasrallah H, El Noueiri B, Pilipili C, Ayoub F. Clinical and Radiographic Evaluations of Biodentine™ Pulpotomies in Mature Primary Molars (Stage 2). Int J Clin Pediatr Dent 2018;11(6):496-504

show abstract

Section: Discussionmentioning

confidence: 99%